Protalix BioTherapeutics, Inc. (PLX) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $2.71 (+0.19%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
PLX vs Sector & Market
| Metric | PLX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +121.8% | +22243.6% | +21.5% |
| P/E Ratio | 14.77 | 3.75 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $14M | $14M | $14M | 1 |
| 2026-12-31 | $15M | $15M | $15M | 1 |
| 2027-03-31 | $16M | $16M | $16M | 1 |
| 2027-06-30 | $18M | $18M | $18M | 1 |
| 2027-09-30 | $20M | $20M | $20M | 1 |
| 2027-12-31 | $23M | $23M | $23M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2026-12-31 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-03-31 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-06-30 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-09-30 | $0.04 | $0.04 | $0.04 | 1 |
| 2027-12-31 | $0.08 | $0.08 | $0.08 | 1 |
Frequently Asked Questions
What is the analyst consensus for PLX?
The consensus among 1 analysts covering Protalix BioTherapeutics, Inc. (PLX) is Buy with an average price target of $6.00.
What is the highest price target for PLX?
The highest analyst price target for PLX is $6.00.
What is the lowest price target for PLX?
The lowest analyst price target for PLX is $6.00.
How many analysts cover PLX?
1 analysts have issued ratings for Protalix BioTherapeutics, Inc. in the past 12 months.
Is PLX a buy or sell right now?
Based on 1 analyst ratings, PLX has a consensus rating of Buy (2.00/5) with a +121.8% upside to the consensus target of $6.00.
What are the earnings estimates for PLX?
Analysts estimate PLX will report EPS of $-0.01 for the period ending 2026-09-30, with revenue estimated at $14M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.